Advertisement

Search Results

Advertisement



Your search for The ASC matches 3 pages

Showing 1 - 3


Erratum: Adoptive Cell Therapy—Act 1: The Beginning

In the September 25, 2017, issue of The ASCO Post, page 1, the date of approval was cited incorrectly for the genetically engineered T-cell therapy tisagenlecleucel (Kymriah). The U.S. Food and Drug Administration approved tisagenlecleucel on August 30, 2017. The T-cell therapeutic is approved for...

sarcoma

ESMO Asia 2016: First Data Presented on Rare Sarcomas in Asian Patients

The first data on rare sarcomas in Asian patients were presented in three studies at the ESMO Asia 2016 Congress in Singapore. Just half of patients with advanced angiosarcoma received chemotherapy, although it improved overall survival. CIC-rearranged sarcomas were associated with a much worse...

breast cancer
issues in oncology

The New Frontiers of Breast Cancer

A seismic shift is underway in screening and treatment approaches for breast cancer. These changes are being fueled by studies showing that mammography in younger women may do more harm than good and that advances in genomic testing and a better understanding of the biology of breast cancers may...

Advertisement

Advertisement



;
Advertisement